Deflazacort

地夫可特

Report date: 2026/05/26 20:00:28
NMEFirst In Class

Base Information

Drug NameDeflazacort
Drug Alias Name去氟可特Deflazacortum地氟可特OxazacortAzacort +[15] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsRenal InsufficiencyHepatic InsufficiencyMuscular Dystrophy, Duchenne +[5] 
Global Approved IndicationsMuscular Dystrophy, Duchenne
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date1985/01/01
Country/TerritoryCanadaUnited StatesSweden +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesMarathon Pharmaceuticals LlcGuidotti
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsRenal InsufficiencyHepatic InsufficiencyMuscular Dystrophies, Limb-Girdle +[4] 

Other Information

ATC CodeH02AB13
Related LinksWikipediaDrugBankKEGG